- Home
- FCN vs ELAN Comparison
FCN vs ELAN Comparison
Compare FCN & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCN
- ELAN
- Stock Information
- Founded
- FCN 1982
- ELAN 1954
- Country
- FCN United States
- ELAN United States
- Employees
- FCN N/A
- ELAN N/A
- Industry
- FCN Professional Services
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- FCN Consumer Discretionary
- ELAN Health Care
- Exchange
- FCN Nasdaq
- ELAN Nasdaq
- Market Cap
- FCN 7.2B
- ELAN 6.3B
- IPO Year
- FCN 1996
- ELAN 2018
- Fundamental
- Price
- FCN $194.96
- ELAN $13.97
- Analyst Decision
- FCN Strong Buy
- ELAN Buy
- Analyst Count
- FCN 1
- ELAN 6
- Target Price
- FCN $275.00
- ELAN $17.00
- AVG Volume (30 Days)
- FCN 285.2K
- ELAN 4.5M
- Earning Date
- FCN 10-24-2024
- ELAN 11-07-2024
- Dividend Yield
- FCN N/A
- ELAN N/A
- EPS Growth
- FCN 28.86
- ELAN N/A
- EPS
- FCN 8.71
- ELAN 0.41
- Revenue
- FCN $3,728,412,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- FCN $7.62
- ELAN $2.22
- Revenue Next Year
- FCN $5.01
- ELAN $2.77
- P/E Ratio
- FCN $22.39
- ELAN $33.88
- Revenue Growth
- FCN 11.66
- ELAN 1.99
- 52 Week Low
- FCN $185.93
- ELAN $11.40
- 52 Week High
- FCN $243.60
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- FCN 30.84
- ELAN 56.31
- Support Level
- FCN $197.64
- ELAN $12.35
- Resistance Level
- FCN $209.13
- ELAN $14.71
- Average True Range (ATR)
- FCN 4.25
- ELAN 0.49
- MACD
- FCN -0.09
- ELAN 0.19
- Stochastic Oscillator
- FCN 11.55
- ELAN 67.29
About FCN FTI Consulting Inc.
FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance and restructuring, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.